In breast cancer cells and mutant p53-KI mouse model of Li-Fraumeni Syndrome, phosphorylation-dependent prolyl-isomerase, Pin1, has shown to augment mutant p53 GOF activities including cellular migration and invasion marked as CSC properties (231, 232). Here, TP53 is linked to breast carcinoma.